XEMC:CA:TSX-iShares MSCI Emerging Markets ex China Index ETF (CAD)

ETF | Others |

Last Closing

CAD 45.05

Change

+0.52 (+1.17)%

Market Cap

N/A

Volume

100.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.60 (+1.93%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.46 (+1.64%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.47 (-1.79%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.80 (+2.46%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.11 (+0.24%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.13 (-1.18%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.03 (+0.13%)

CAD 2.78B

ETFs Containing XEMC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.76% 47% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.76% 46% F 42% F
Trailing 12 Months  
Capital Gain -0.90% 29% F 32% F
Dividend Return 0.69% 18% F 10% F
Total Return -0.22% 24% F 27% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.35% 70% C- 59% D-
Dividend Return 7.56% 69% C- 54% F
Total Return 0.21% 26% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 8.37% 60% D- 79% B-
Risk Adjusted Return 90.34% 93% A 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.